Nouryon has signed a long-term agreement with Arauco for the supply of sodium chlorate and chlorine dioxide for Arauco's new $4.6 billion pulp mill in Mato Grosso do Sul, Brazil.
AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the US.
Chevron Phillips Chemical has successfully completed the expansion of its low-viscosity polyalphaolefins production unit in Beringen, Belgium, boosting its manufacturing capacity in Europe.
Bionova Scientific has opened a 10,000 square-foot state-of-the-art plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
Asahi Kasei Life Science, a division of global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.
Sygnature Discovery, an integrated drug discovery CRO, has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure following a £1 million investment.
AstraZeneca recently announced $50 billion of investment in the US by 2030. This investment is expected to create tens of thousands of new, highly skilled jobs nationwide.
Sanner, a provider of high-quality healthcare packaging and drug delivery solutions, officially opened its first US-based production facility in Greensboro, North Carolina.
Ineos has completed a major £30 million investment at its Hull manufacturing site, converting the facility to run on clean-burning hydrogen instead of natural gas. This results in a 75% cut in carbon emissions.
The Flamma Group, a Contract Development and Manufacturing Organization (CDMO), recently celebrated the grand opening of a new cGMP plant in Dalian, China.
Arkema is building an additional unit at its Singapore site to produce Rilsan Clear, a transparent polyamide. With an investment of $20 million, the site is expected to open in early 2026.
In a new building at the Wacker Consortium, the company's central research site, researchers are working on new manufacturing processes for biopharmaceuticals and ingredients for food and nutritional supplements.
IMCD recently announced the opening of its newly reorganised and expanded Life Science Laboratory hub in Shanghai.
Pace Life Sciences, a US-based contract research, development, and manufacturing organization (CRDMO), is remodeling and expanding its Salem, NH site for aseptic fill-finish processing.
WeylChem Wesseling has announced its entry into the Advanced Materials market with the formation of a new Advanced Materials Business Line in Germany.
ENEOS and Mitsubishi Chemical have completed their chemical recycling facility at Mitsubishi Chemical’s Ibaraki Plant in Kamisu City, Ibaraki Prefecture, Japan.
Nippon Shokubai recently announced plans to expand its GMP-compliant manufacturing capacity for nucleic acid drug active pharmaceutical ingredients (APIs) tenfold.
CATL and its partners have started construction on a $6 billion battery integration project in West Java, Indonesia.
Hikma Pharmaceuticals USA announces $1 billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines.
The biopharmaceutical company Sanofi in Germany and the industrial park operator Infraserv Höchst laid the foundation stone for a state-of-the-art office building in the south of the industrial park.
AGC Biologics began its cell therapy process development and clinical manufacturing services on July 1, 2025, at its Yokohama Technical Center in Japan.
Peróxidos do Brasil, a joint venture between Solvay and Produtos Químicos Makay (PQM), announces a new strategic investment in its production unit in Chile.
Axplora to expand its Farmabios site in Gropello Cairoli, Italy, with a €35 million investment.
Vetter broke ground for the start of construction of its new clinical site in Des Plaines, Illinois, US on June 26.
Aenova is investing in a new cold storage infrastructure at its sterile site in Latina (Italy), offering an end-to-end supply chain solution for biologics and other pharmaceutical products.
Sika has acquired Gulf Additive Factory in the State of Qatar. The company manufactures a wide range of construction chemical products.
Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK.
The Innovation Center will focus on research and development for sustainable drilling and completion, production, and stimulation processes, and will also serve as a platform for workshops and training sessions.
Neoenergia began construction of one of the first green hydrogen (H2V) power plants Brazil, located in Taguatinga with an investment of more than R$ 30 million (€ 4.7 million).
BASF has opened a new Good Manufacturing Practice (GMP) Solution Center in Wyandotte, Michigan, to support the supply of bioprocessing ingredients and excipients for the biopharma and pharmaceutical industries.
BASF has announced the successful startup of its new world-scale hexamethylenediamine (HMD) plant in Chalampé, France, construction of which began in 2022.
Syensqo, a global company specializing in advanced materials and specialty chemicals, has announced the opening of new microbiology, (eco-)toxicology, and biotechnology laboratories in Lyon, France.
Schott Pharma is investing more than €100 million in its existing site in Lukácsháza, Hungary, to expand its capacity for sterile ready-to-use (RTU) cartridges.
DuPont announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica.
